Posts

Fordham 33 (Report 4): Life sciences and healthcare innovation

Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen

UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21

Fordham 32 (Report 1): Patents in Pharma

Sunday Surprises

UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471)

Sweden gets into the Article 3 SPC referral game in AstraZeneca dapagliflozin case

How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently

A new study on the options for a unified supplementary protection certificates (SPCs) system in Europe!

After Michael Jordan: a new typical case on what is the right of likeness under the Civil Code of China